EcoDrugPlus

Histone Deacetylase 8

Ensembl ID : ENSSTUG00000002071
Gene Symbol: HDAC8
1 Cross references
200 Possible Orthologues:

Histone-Lysine N-Methyltransferase Ezh2-Like

Ensembl ID : ENSSTUG00000029543
Gene Symbol: LOC115195415
3 Cross references
232 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSSTUG00000010994
Gene Symbol: HCN4
3 Cross references
213 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSSTUG00000039055
Gene Symbol: HCRTR2
3 Cross references
203 Possible Orthologues:

Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 Homolog

Ensembl ID : ENSSTUG00000048400
Gene Symbol: LOC115176776
3 Cross references
152 Possible Orthologues:

Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 Homolog

Ensembl ID : ENSSTUG00000000195
Gene Symbol: LOC115178942
3 Cross references
153 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSSTUG00000047760
Gene Symbol: IKBKB
3 Cross references
195 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSSTUG00000027659
Gene Symbol: IMPDH1
3 Cross references
189 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSSTUG00000035744
Gene Symbol: IMPDH1
3 Cross references
251 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSSTUG00000037947
Gene Symbol: IMPDH1
3 Cross references
252 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSSTUG00000035405
Gene Symbol: IMPDH2
3 Cross references
194 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1a-Like

Ensembl ID : ENSSTUG00000033085
Gene Symbol: LOC115196661
3 Cross references
251 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).